Erasmus University Medical Centre, Department of Gastroenterology and Hepatology, 's Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands.
Gut. 2013 Mar;62(3):409-15. doi: 10.1136/gutjnl-2011-301583. Epub 2012 Mar 2.
Colorectal cancer screening by means of faecal immunochemical tests (FITs) requires successive screening rounds for an optimal preventive effect. However, data on the influence of the length of the screening interval on participation and diagnostic yield are lacking. Repeated FIT screening was therefore performed in a population-based trial comparing various repeat intervals.
7501 Dutch individuals aged 50-74 years were randomly selected and invited for two 1-sample FIT screening rounds (haemoglobin (Hb) concentration ≥ 50 ng/ml, corresponding to 10 μg Hb/g faeces) with intervals of 1 (group I), 2 (group II) or 3 years (group III).
In group I, participation was 64.7% in the first screening round and 63.2% in the second. The corresponding percentages for groups II and III were 61.0% vs 62.5% and 62.0% vs 64.0%. Triennial screening resulted in a higher participation rate in the second screening round compared with annual screening (p=0.04). The overall positivity rate in the second screening round was significantly lower compared with the first round (6.0% vs 8.4%; OR 0.69, 95% CI 0.58 to 0.82) and did not depend on interval length (p=0.23). Similarly, the overall detection rate of advanced neoplasia was significantly lower in the second round compared with the first screening round (1.9% vs 3.3%; OR 0.57, 95% CI 0.43 to 0.76) and also did not depend on interval length (p=0.62). The positive predictive value of the FIT did not significantly change over time (41% vs 33%; p=0.07).
The total number of advanced neoplasia found at repeat FIT screening is not influenced by the interval length within a range of 1-3 years. Furthermore, there is a stable and acceptably high participation in the second screening round. This implies that screening intervals can be tailored to local resources.
通过粪便免疫化学检测(FIT)进行结直肠癌筛查需要进行连续的筛查轮次,以达到最佳的预防效果。然而,关于筛查间隔时间长短对参与度和诊断收益的影响的数据尚缺乏。因此,我们在一项基于人群的试验中对不同重复间隔时间进行了重复 FIT 筛查。
7501 名年龄在 50-74 岁的荷兰人被随机选择,并邀请他们参加两轮 1 份粪便样本 FIT 筛查(血红蛋白(Hb)浓度≥50ng/ml,对应粪便中 10μg Hb/g),间隔时间分别为 1 年(第 I 组)、2 年(第 II 组)或 3 年(第 III 组)。
第 I 组第一轮筛查的参与率为 64.7%,第二轮为 63.2%。第 II 组和第 III 组的相应百分比分别为 61.0%比 62.5%和 62.0%比 64.0%。与每年筛查相比,每 3 年筛查在第二轮筛查中的参与率更高(p=0.04)。第二轮筛查的总体阳性率明显低于第一轮(6.0%比 8.4%;OR 0.69,95%CI 0.58 至 0.82),且与间隔时间无关(p=0.23)。同样,第二轮筛查中晚期肿瘤的总体检出率明显低于第一轮(1.9%比 3.3%;OR 0.57,95%CI 0.43 至 0.76),也与间隔时间无关(p=0.62)。FIT 的阳性预测值随时间推移没有明显变化(41%比 33%;p=0.07)。
在 1-3 年的范围内,重复 FIT 筛查中发现的晚期肿瘤总数不受间隔时间的影响。此外,第二轮筛查的参与率稳定且可接受地高。这意味着筛查间隔时间可以根据当地资源进行调整。